Literature DB >> 6353319

Antibody-dependent ingestion of P. falciparum merozoites by human blood monocytes.

S Khusmith, P Druilhe.   

Abstract

The binding of malarial antibodies to peripheral blood monocytes and the ability of these armed monocytes to attach to and ingest P. falciparum merozoites and schizont infected erythrocytes was evaluated by an in vitro assay. Monocytes from normal unsensitized subjects were preincubated with sera from individuals with various states of immunity to malaria and sera from normal controls. A marked difference in the level of merozoite phagocytosis was observed depending on immune status of the individuals whose sera were tested, but not on the antibody levels measured by fluorescence or precipitation tests. By protein-A-sepharose fractionation of these sera it appeared that the merozoite phagocytosis was mediated by immunoglobulin of the IgG class. Immunoglobulins eluted from these preincubated monocytes were able to bind to the parasites as detected by indirect fluorescent test. Similar assays performed with different strains and antibodies from various geographical areas indicated that the merozoite recognition and ingestion was not strain specific. The monocyte-immunoglobulin co-operation was effective in the phagocytosis of merozoites but not of schizont infected erythrocytes or normal erythrocytes. However, some degree of adhesion to the schizonts was recorded. These data seem to indicate that human blood monocytes can be specifically armed in vitro by cytophilic IgG with antimalarial specificity, and that such an effect is able to enhance markedly the clearance of free parasites but not of intact schizonts.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6353319     DOI: 10.1111/j.1365-3024.1983.tb00751.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  13 in total

1.  Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry.

Authors:  L M Kumaratilake; A Ferrante
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status.

Authors:  P Druilhe; S Khusmith
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

3.  Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum.

Authors:  L M Kumaratilake; A Ferrante; C M Rzepczyk
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 4.  Malaria: immunity, vaccination and immunodiagnosis.

Authors:  L Perrin; A Perez; C Chizzolini
Journal:  Experientia       Date:  1984-12-15

5.  The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis.

Authors:  Sarah Hochman; Kami Kim
Journal:  J Neuroparasitology       Date:  2012-03-02

6.  Altered expression of human monocyte Fc receptors in Plasmodium falciparum malaria.

Authors:  K N Ward; M J Warrell; J Rhodes; S Looareesuwan; N J White
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

7.  Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum.

Authors:  D Salmon; J L Vilde; B Andrieu; R Simonovic; J Lebras
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

8.  Phagocytosis does not play a major role in naturally acquired transmission-blocking immunity to Plasmodium falciparum malaria.

Authors:  J Healer; A Graszynski; E Riley
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

9.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.

Authors:  H Bouharoun-Tayoun; C Oeuvray; F Lunel; P Druilhe
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

10.  Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites.

Authors:  Danika L Hill; Emily M Eriksson; Amandine B Carmagnac; Danny W Wilson; Alan F Cowman; Diana S Hansen; Louis Schofield
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.